Influenza roadmap:
Vaccines
Roadmap for the development of candidate vaccines for influenza
Download Influenza-vaccine-development-roadmap9
Adjuvant
Dependencies
Next steps
- 4 Inactivated vaccines
- 4A Safety
- 4B Delivery route
- 4C Delivery platform
- 4D Efficacy in challenge model
- 5 DNA/RNA
- 5A Safety
- 5B Delivery route
- 5C Delivery platform
- 5D Efficacy in challenge model
- 6 Subunit vaccines
- 6A Safety
- 6B Delivery route
- 6C Delivery platform
- 6D Efficacy in challenge model
Adjuvant
Research Question
- New adjuvant stimulating durable immune response and no adverse reaction for the animal
Research Gaps and Challenges
- Promote an appropriate immune response with reduced amount of
antigen - Withdrawal time of adjuvant in livestock production systems
- Adjuvants to improve/broad responses using vectors or attenuated
organisms - Stability, safety and immunogenicity at a feasible cost
- Adjuvants are primarily targeted to antibody response: harder to
measure mucosal or cellular response and this limits field of application
Solution Routes
- Better understanding of the mechanisms and immune – system – wide effects of new and existing adjuvants to enable rational design of improved vaccines with rapid onset of broadly – protective humoral, cellular and innate immunity
- Development of vaccines/adjuvants to induce broad/universal clinical cross-protection
- Mucosal adjuvants for IN application in swine/equine? and spray in
poultry - Studies to establish the most suitable molecular adjuvants for nucleic acid-based vaccines that could be used in food producing species
Projects
What activities are planned or underway?
Development of Vaccines for HPAI in Cattle, Turkey, Pigs, and Small Ruminants and Food Safety Studies Related to HPAI Virus in Food Products
Planned Completion date 25/08/2029
Source Countries:
United States
Automated non-invasive Detection of Surface Contamination and Optimizing Surface Biofilm Removal Conditions in Large-Scale Food Processing Equipment
Planned Completion date 31/08/2028
Source Countries:
United States